NCT06570629

Brief Summary

Oral unintentional leak is a common side effect of continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA) treatment. Management of oral unintentional leakage has not been standardized and the effectiveness of potential approaches have not been studied in controlled studies. Higher levels of CPAP are associated with higher leak. In the present study, a sequential approach to control excessive unintentional leak will be tested. In study A, the reduction of therapeutic CPAP level will be tested. In study B, oronasal CPAP will be compared to nasal CPAP with a chinstrap.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
33mo left

Started Apr 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Apr 2025Dec 2028

First Submitted

Initial submission to the registry

January 25, 2024

Completed
7 months until next milestone

First Posted

Study publicly available on registry

August 26, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

April 30, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Expected
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

8 months

First QC Date

January 25, 2024

Last Update Submit

April 27, 2025

Conditions

Keywords

CPAPExcessive leakObstructive Sleep Apnea

Outcome Measures

Primary Outcomes (1)

  • 95th CPAP unintentional leak

    The 95th unintentional leak percentile value will be compared during both interventions

    27 days

Secondary Outcomes (4)

  • CPAP Side-effects questionnaire

    27 days

  • Residual apnea-hypopnea index (AHI)

    27 days

  • Functional Outcomes of Sleep Questionnaire (FOSQ 10)

    27 days

  • Pittsburgh questionnaire

    27 days

Study Arms (2)

Oronasal CPAP

EXPERIMENTAL

CPAP with an oronasal mask for 7 days.

Device: Oronasal CPAP

Chinstrap

EXPERIMENTAL

CPAP with a nasal mask and a chinstrap for 7 days.

Device: Nasal CPAP plus Chinstrap

Interventions

In this crossover trial, subjects will use CPAP with either an oronasal mask or a. nasal mask with a chinstrap for 7 days. The order of each intervention will be randomized.

Oronasal CPAP

In this crossover trial, subjects will use CPAP with either an oronasal mask or a. nasal mask with a chinstrap for 7 days. The order of each intervention will be randomized.

Chinstrap

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of moderate and severe obstructive sleep apnea;
  • Use of CPAP with a nasal mask;
  • th percentile of unintentional leak from the last 7 days above 24 l/min, or at least 4 sudden drops of leak over one night of nasal CPAP
  • Persistence of excessive leak at the end of Study A.

You may not qualify if:

  • Patients who experience unintentional leakage from the mask/accessories.
  • Diagnostic polysomnography examination with a predominance of central apnea;
  • Patients with unstable heart disease, bedridden, neurodegenerative diseases, severe psychiatric disorders and COPD;
  • Previous surgery for obstructive sleep apnea;
  • Severe nasal obstruction (NOSE questionnaire score equal or greater then 55 points).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sleep Laboratory, Heart Institute, Pulmonary Division, Hospital das Clínicas da Universidade de São Paulo

São Paulo, Brazil, 55, Brazil

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Pedro Genta

    Study Principal Investigator

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 25, 2024

First Posted

August 26, 2024

Study Start

April 30, 2025

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2028

Last Updated

April 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations